Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Price Discrimination Across Indications in the Pharmaceutical Industry: The Case of Finasteride
Download
100-100-1-PB.pdf
Date
2006-6
Author
Başlevent, Cem
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
8
views
29
downloads
Cite This
This paper examines the price differential between two prescription drugs (Proscar and Propecia) which contain the same active ingredient (finasteride) in different dosages. It is argued that the price differential is an example of price discrimination across indications of the same substance.
URI
http://www2.feas.metu.edu.tr/metusd/ojs/index.php/metusd/article/view/100
https://hdl.handle.net/11511/58397
Journal
METU Studies in Development
Collections
Department of Economics, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
C. Başlevent, “Price Discrimination Across Indications in the Pharmaceutical Industry: The Case of Finasteride,”
METU Studies in Development
, vol. 33, no. 1, pp. 155–160, 2006, Accessed: 00, 2020. [Online]. Available: http://www2.feas.metu.edu.tr/metusd/ojs/index.php/metusd/article/view/100.
